Testo Pro
Testo Pro, licence 80048900: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- Swole Sports Nutrition
- NPN or DIN-HM
- 80048900
- Status
- Active licence
- Licence date
- 4 March 2014
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Trigonella foenum-graecum L.: L'étiquetage doit comporter un avertissement déconseillant l'emploi aux femmes enceintes.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Lepidium meyenii Walp.: L'absence d'alcaloïdes doit être démontrée par des rapports d'analyse.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Zinc Source : Gluconate de zinc | 1.7 mg | 5,100 µg |
| Trigonella foenum-graecum Source : Graine(s) Extraction ratio : 4:1 Dry plant equivalent : 366.68 mg Potency : 50.0 % Saponins | 91.67 mg | Not calculated |
| Lepidium meyenii Source : Racine Extraction ratio : 4:1 Dry plant equivalent : 400 mg | 100.0 mg | Not calculated |
Non-medicinal ingredients
farine de riz, Dioxyde de silicium, Stéarate de magnésium, Gélatine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 3.0 Capsule | 1.0 Jour(s) |
Uses authorised in Canada
Provides antioxidants. Helps in connective tissue formation. Helps to maintain healthy skin and immune function. Helps the body to metabolize carbohydrates, fats and proteins.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Effets indésirables connus
Hypersensitivity/allergy has been known to occur. If this is the case, discontinue use. Diuretic effect may occur. If dizziness, vomiting, dry mouth, thirst or nosebleed occur, discontinue use.
- Précautions et mises en garde
If symptoms persist or worsen, consult a health care practitioner. If you are pregnant or breastfeeding, consult a health care practitioner prior to use. If you are taking antidepressants, blood thinners or if you have diabetes or high blood pressure consult a healthcare practitioner prior to use. If you suffer from a hormone-sensitive condition, consult a healthcare practitioner.
Source
Official Health Canada record, licence 80048900
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.